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Saving our newborns by doing the basics 
right – and keeping it simple
Just basic interventions 
could reduce South Africa 
(SA)’s neonatal death rate 
by up to 90%, according to 
a world-acclaimed inno-
vator in cheap, child-friendly therapies, 
Prof. Heather Zar, chief of Paediatrics and 
Child Health at Red Cross War Memorial 
Children’s Hospital in Cape Town.
In view of the absence of significant 
reduction in SA’s neonatal mortality rate 
over the past decade and the country failing 
dismally to reach this year’s Millennium 
Development Goal (MDG) of reducing its 
1990 child mortality rate by two-thirds, 
Izindaba quizzed Zar on the most vital 
interventions required.
Antenatal steroids to mature a baby’s lungs 
when its mother is in preterm labour, the 
now world-famous kangaroo care, exclusive 
breastfeeding, optimal labour and delivery 
management, neonatal resuscitation and optimal 
postnatal care including appropriate treatment 
of neonatal sepsis would, taken together, send 
the neonatal death rate plummeting, she said.
In preventing preterm delivery, better ante-
natal and obstetric care would also go a long 
way to ensure safer delivery and effective subse-
quent postnatal care, she added. When it came 
to reducing under-5 mortality (another MDG 
SA didn’t achieve), several well-known effective 
preventive strategies such as immunisation, 
optimising nutrition, breastfeeding, provision of 
antiretroviral therapy and prevention of mother-
to-child transmission (PMTCT) of HIV were 
required. As neonatal deaths make up almost 
a third of under-5 deaths, strategies to reduce 
deaths in the first 28 days of life (and especially 
in the first 7 days) could have a big impact on the 
under-5 mortality rate.
Where we have done  
well …
The above are all areas in which SA has 
improved by varying degrees, especially 
PMTCT, where major reductions in HIV 
infections have for the first time put almost 
zero transmission within reach, achieving 
world acclaim. Vaccines for children were 
a growing local success story, with rates of 
invasive pneumococcal disease – including 
cases caused by antibiotic-resistant bacteria – 
having fallen substantially following the 
introduction of a pneumococcal conjugate 
vaccine. The rate of infections resistant 
to two different antibiotics had declined 
nearly twice as much as that for infections 
that could be treated with antibiotics. This 
proportionately greater effect of vaccination 
on antibiotic-resistant strains pointed to a 
very valuable added benefit of immunisation. 
Zar said that a maternal influenza vaccine 
during pregnancy had also recently been 
shown to substantially reduce influenza in 
mothers and their babies, and was a strategy 
that should be strengthened as a matter of 
urgency. Despite official and scientifically 
backed recommendations for the influenza 
vaccine to be prioritised for pregnant women, 
uptake remained very low.
Zar described as ‘very exciting’ current 
overseas work on the development of a 
vaccine for respiratory syncytial virus (RSV), 
which causes infections of the lungs and 
respiratory tract. RSV is so common that 
most children have been infected with it by 
age 2. In adults and older, healthy children, 
the symptoms of respiratory syncytial virus 
are mild and typically mimic the common 
cold. Self-care measures are usually all that 
are needed to relieve any discomfort, but 
infection can be severe in in premature 
babies and infants with underlying health 
conditions (and in older adults, adults with 
heart and lung diseases, or anyone with a 
very weak immune system). Zar said that 
a major part of her enthusiasm was due to 
the strategy to immunise pregnant women 
against RSV as a way of protecting their 
infants.
Overall, she said, strengthening health 
systems, reducing poverty and improving the 
coverage and uptake of these known effective 
interventions would see SA beginning to 
make quicker, long-awaited progress in 
reducing the neonatal mortality and under-5 
mortality (and morbidity) rates.
Leading by example with 
innovation
Zar, a past president of the South African 
Thoracic Society and president of the Pan 
African Thoracic Society, currently chairs 
the Forum of the International Respiratory 
Societies. She achieved world acclaim with 
her low-cost plastic cooldrink bottle spacer for 
asthmatic children, which rendered what used 
to be expensive inhalers accessible to millions 
of children in poorer communities. Her 
invention made the oral alternative therapy, 
theophylline (a white crystalline alkaloid 
and vasodilator with several unpleasant 
side-effects), a thing of the past. The use 
of cooldrink bottles as asthma spacers is 
now included in guidelines from the Global 
Initiative for Asthma and the World Health 
Organization (WHO). Another surprisingly 
simple advance that she and her Red Cross 
War Memorial Hospital team came up with – 
now also included in WHO guidelines and 
national recommendations – is the use of 
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less invasive sputum induction for rapid 
tuberculosis (TB) testing in children. A few 
years ago it was widely believed that children 
couldn’t provide enough sputum for a TB 
test. Instead doctors used gastric lavage or 
stomach pumping, a process that involved 
starving a child overnight, then sticking a 
tube down their nostrils or throat into their 
stomach, and sucking all the contents out. 
Children were subjected to this process three 
days in a row before doctors could retrieve a 
specimen large enough for testing. Zar and 
her team found that by nebulising a child 
beforehand and suctioning the back of their 
throat very quickly, it is possible to induce 
enough sputum for a rapid TB test (using 
GeneXpert). This retrieves a better specimen 
than that from three days of gastric irrigation.
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